AmbioPharm plans $119M expansion in Aiken County, more jobs

A peptide manufacturer and developer today, June 16, announced it is expanding its operations in Aiken County. The company’s $118.96 million investment will create 202 new jobs, according to the state Commerce Department.

Founded in 2005, AmbioPharm Inc. is headquartered in North Augusta and specializes in developing highly efficient peptide manufacturing processes for peptide-based active pharmaceutical ingredients (APIs) at small to very large scales, according to a news release. The company manufactures new chemical entities and peptide APIs under current good manufacturing practice (GMP) regulations for clients worldwide.

As part of its expansion, AmbioPharm will construct a modular manufacturing building at its existing South Carolina campus, located at 1024 Dittman Court in North Augusta. The facility will offer commercial-scale GMP synthesis, solid-phase peptide synthesis, liquid-phase peptide synthesis and hybrid approaches, all supported by semi-automated production systems and advanced solvent delivery infrastructure, the release stated.

“As the global demand for peptide therapeutics accelerates, the need for dependable U.S. manufacturing is extremely important,” AmbioPharm CEO Brian Gregg said in the release. “This expansion enhances our ability to support our client-partners with scalable, high-quality production while creating new opportunities for skilled talent in Aiken County.”

Operations are expected to be online by the end of 2027.

“I am pleased that AmbioPharm has chosen to make this significant investment in Aiken County,” Gary Bunker, County Council chairman, said in the release. “The company’s expansion, totaling nearly $119 million and creating 202 new jobs, is a tremendous vote of confidence in our community, our workforce and our business climate. AmbioPharm has been a valued member of our corporate community, and the Aiken County Council is proud of their growth and success. This announcement further strengthens Aiken County’s position as a leader in advanced manufacturing and life sciences.”

Individuals interested in joining the AmbioPharm can learn more on the company’s careers page.

“We are proud to celebrate AmbioPharm’s continued growth and commitment to North Augusta and Aiken County,” Western SC Economic Development Partnership Chairman Richard Pendarvis said in the release. “This $118.96 million expansion and the creation of 202 new jobs represent a significant investment in our community and our workforce. AmbioPharm’s success demonstrates the strength of our region as a destination for advanced manufacturing and life sciences, and we look forward to supporting the company’s continued growth for years to come.”

In May, CordenPharma, a company based in Basel, Switzerland, announced that it had entered into an agreement to acquire AmbioPharm, which also has a manufacturing facility in China. CordenPharma has 11 sites in Europe and North America.